[94] have described isoforms MT1M and MT1G as potential noninvasive biomarkers for HCC, as their serum concentration was significantly higher than in patients with chronic hepatitis B and was positively correlated with the tumor size. The gene discussed is MT1M; the disease is neoplasm.